Search results

1. ASCO 2024 – AstraZeneca’s GPC3 secret sauce

   ASCO 2024 – AstraZeneca’s GPC3 secret sauce …

   
    

   Jacob Plieth
    
   - 06/06/2024 - 19:22

2. ASCO 2024 – J&J shifts to a new radiopharma dosing strategy

   ASCO 2024 – J&J shifts to a new radiopharma dosing …

   
    

   Madeleine Armstrong
    
   - 06/04/2024 - 17:26

3. ASCO 2024 – IDRx shoots for an early-line gist

   ASCO 2024 – IDRx shoots for an early-line gist … with IDRX-42 in GIST Venue CTOS Nov 2023 ASCO 2024 abstract May 2024 ASCO 2024 presentation Jun 2024 Cutoff date 5 …

   
    

   Madeleine Armstrong
    
   - 01/13/2025 - 09:40

4. ASCO 2024 – two more Echelon-3 surprises

   ASCO 2024 – two more Echelon-3 surprises …

   
    

   Jacob Plieth
    
   - 06/03/2024 - 00:48

5. ASCO 2024 – Pfizer’s KAT6 inhibitor purrs

   ASCO 2024 – Pfizer’s KAT6 inhibitor purrs …

   
    

   Madeleine Armstrong
    
   - 06/03/2024 - 00:47

6. ASCO 2024 – USP1 lives on, for now

   ASCO 2024 – USP1 lives on, for now …

   
    

   Jacob Plieth
    
   - 06/03/2024 - 00:48

7. ASCO 2024 – acasunlimab impresses on overall survival

   ASCO 2024 – acasunlimab impresses on overall survival … date 22 Mar 2024 for ORR & 1 May 2024 for OS. Source: ASCO 2024 poster. Conferences …

   
    

   Madeleine Armstrong
    
   - 06/03/2024 - 00:48

8. ASCO 2024 – AbbVie sees SEZ6 improvement

   ASCO 2024 – AbbVie sees SEZ6 improvement …

   
    

   Madeleine Armstrong
    
   - 06/03/2024 - 19:15

9. ASCO 2024 – Blenrep “should return” to the US

   ASCO 2024 – Blenrep “should return” to the US …

   
    

   Jacob Plieth
    
   - 06/03/2024 - 01:15

10. ASCO 2024 – Enhertu nears its “ultralow” dream

    ASCO 2024 – Enhertu nears its “ultralow” dream …

    
     

    Jacob Plieth
     
    - 06/03/2024 - 21:09